Med-IQ

Course Listings: Cardiology

All Results (7)
Format: Live Events (0) Online Activities (7)

Decision-IQ: When Is PCSK9 Inhibitor Therapy Beneficial?

View Course

Format: Decision-IQ

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute educational activity highlights current evidence on the use of PCSK9 inhibitors in patients with dyslipidemia via critical case assessment that emulates the decision-making process during patient care visits. Links to useful resources are provided for a self-directed dive into recent data on patient- and disease-related factors important in…More


Recognizing Residual Inflammatory Risk and Preventing Recurrent Events in Patients With Atherosclerotic Cardiovascular Disease

Resume Course

Format: Presentation Points

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This Presentation Points accredited CME publication features transcript-based faculty commentary, expert insight, and key educational takeaways from a satellite symposium at the American Heart Association’s Scientific Sessions 2017, led by Christie M. Ballantyne, MD, and Paul M. Ridker, MD. In particular, areas of focus include the role of innate immunity in…More


Recognizing the Risk and Providing Optimal Care to Veterans With Heart Failure

Resume Course

Format: PDF Publication

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 Accreditation Council for Pharmacy Education (ACPE)
  • 1.0 American Nurses Credentialing Center (ANCC)

Course Description: This publication explores risk factors for heart failure that are unique to veterans and reviews treatment strategies based on the updated heart failure guidelines. The clinical trials that led to these updated guidelines are also discussed.


Optimal Antithrombotic Therapies After ACS: Examining the Findings From the GEMINI-ACS-1 Trial

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute activity features a brief video introduction by faculty expert Dr. Ohman in which he discusses the rationale for and implications of the GEMINI-ACS-1 trial. The activity then continues with a text-based review of current standards of care for post-ACS treatment and clinical trials on triple-antithrombotic and dual-pathway therapies.


Clinical Conundrums in a Patient Presenting With Weight Loss and Multiple Other Complaints: Can You Diagnose This Disease?

View Course

Format: Simulation

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)

Course Description: In this video-enhanced, CME-certified simulation, clinicians are challenged to appropriately diagnose a patient presenting with multiple complaints, including weight loss. Throughout the activity, clinicians must consider the patient’s medical history and physical evaluation and order appropriate laboratory and diagnostic tests to identify and treat his…More


And the Beat Goes On: Clinical Implications and Real-World Application of Advances in Heart Failure

View Course

Format: Med-IQ Express

    Maximum Credits:
  • 0.25 AMA PRA Category 1 Credit(s)

Course Description: This 15-minute publication begins with a brief video in which a clinical expert discusses guideline updates for the pharmacologic management of patients with chronic heart failure and reduced ejection fraction. The clinical trial data that led to these updated guidelines are further discussed in the publication.


Increasing Physician Awareness of Pulmonary Arterial Hypertension in Systemic Sclerosis

View Course

Format: E-Publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This online CME publication discusses guideline recommendations for pulmonary arterial hypertension (PAH) screening in patients with systemic sclerosis (SSc) and presents key insights on available treatment options for PAH. In addition, this publication is enhanced with audio clips from an expert roundtable discussion on the increased risk of PAH in SSc, signs…More